Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Evonik Cancels IPO, Again …

by Marc S. Reisch
June 25, 2012 | A version of this story appeared in Volume 90, Issue 26

For the third time since 2008, owners of specialty chemical maker Evonik Industries have canceled plans for an initial public offering of stock in the firm because of poor market conditions. RAG Foundation, which owns 75% of Evonik, says uncertainty in capital markets and the economic crisis in Europe mean investors are unwilling to pay an appropriate price for the shares. RAG and CVC Capital Partners, which owns the other 25% of Evonik, announced plans for the most recent offering in late May. According to reports from Germany at the time, the two expected to sell a 25% stake in Evonik and raise as much as $5.6 billion. RAG says it will consider a sale again when investors are willing to pay more.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.